76 related articles for article (PubMed ID: 1561466)
21. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
22. [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
Romeo F; Barillà F; Pelliccia F; Ferraironi A; Ciolli A; Pannarale G; Vicchio D; Valente A
Cardiologia; 1989 Jul; 34(7):643-50. PubMed ID: 2676173
[TBL] [Abstract][Full Text] [Related]
23. [The relationship between the isosorbide-5-mononitrate concentration and its antianginal effect following the administration of regular and prolonged-action drug forms in patients with stenocardia of effort].
Blagodatskikh SV; Martsevich SIu; Metelitsa VI; Kutishenko NP; Kozyreva MP; Simkhaev LS; Slastinkova ID; Vakulovskaia MK
Eksp Klin Farmakol; 1995; 58(3):25-7. PubMed ID: 7663289
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
26. Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
Thadani U; Hamilton SF; Olson E; Anderson JL; Prasad R; Voyles W; Doyle R; Kirsten E; Teague SM
Am J Cardiol; 1987 Apr; 59(8):756-62. PubMed ID: 3825935
[TBL] [Abstract][Full Text] [Related]
27. Induction and circumvention of nitrate tolerance applying different dosage intervals.
Silber S; Vogler AC; Krause KH; Vogel M; Theisen K
Am J Med; 1987 Nov; 83(5):860-70. PubMed ID: 3674093
[TBL] [Abstract][Full Text] [Related]
28. Slow release isosorbide-5-mononitrate therapy in angina pectoris. Effects of exercise performance and hemodynamics.
Jansen W; Prenzel R; Rappert B; Kümper H; Laufen H; Tauchert M
Cardiology; 1991; 79 Suppl 2():78-85. PubMed ID: 1760835
[TBL] [Abstract][Full Text] [Related]
29. [Isosorbide 5-mononitrate (delayed release) in stable effort angina].
Almenar Bonet L; Miró Palau V; Gimeno Gascón JV; Algarra Vidal F
Rev Esp Cardiol; 1992; 45(7):456-61. PubMed ID: 1439070
[TBL] [Abstract][Full Text] [Related]
30. Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina.
Akhras F; Jefferies S; Jackson G
Z Kardiol; 1985; 74 Suppl 4():16-20. PubMed ID: 3938114
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
Shimada K; Sunayama S; Nakazato K; Satoh H; Kusama Y; Kawakubo K; Daida H
Int Heart J; 2006 Sep; 47(5):695-705. PubMed ID: 17106140
[TBL] [Abstract][Full Text] [Related]
32. Effect of sustained release isosorbide dinitrate on exercise performance.
Flugelman MY; Shefer A; Ben David Y; Witt H; Gotsman MS
Cardiology; 1985; 72(3):123-8. PubMed ID: 3995516
[TBL] [Abstract][Full Text] [Related]
33. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
[TBL] [Abstract][Full Text] [Related]
34. Acute and chronic effects of once-daily isosorbide-5-mononitrate on the exercise capacity of patients with angina pectoris treated with a beta-blocking drug.
Eteiba H; Hutton I; Foale RA; Akhras F; Jackson G; Prescott RJ; Hallam RJ; Quinn KJ
Br J Clin Pract; 1991; 45(3):185-8. PubMed ID: 1687200
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
[No Abstract] [Full Text] [Related]
36. [Effects of metoprolol acute administration on effort tolerance in patients affected by stable effort angina. Comparison with placebo and propranolol (author's transl)].
Ferratini M; Pirelli S; Salvadé P; Augello M; De Ponti C; Rovelli F
G Ital Cardiol; 1979; 9(12):1358-62. PubMed ID: 549784
[No Abstract] [Full Text] [Related]
37. [Efficacy and length of action of a slow-release formulation of isosorbide-5-mononitrate in stable effort angina].
Lagioia R; Scrutinio D; Mangini SG; Mastropasqua F; Caporale R; Mancini G; Loliva F; Rizzon P
Cardiologia; 1989 Feb; 34(2):155-60. PubMed ID: 2660992
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.
Thadani U; Prasad R; Hamilton SF; Voyles W; Doyle R; Karpow S; Reder R; Teague SM
Am J Cardiol; 1987 Sep; 60(7):477-82. PubMed ID: 3630929
[TBL] [Abstract][Full Text] [Related]
39. Dose-effect relationship amongst three different sustained-release forms of isosorbide 5-mononitrate in patients with coronary artery disease.
Kenedi P; Gathmann-Lewik U
Cardiology; 1987; 74 Suppl 1():29-33. PubMed ID: 3300975
[TBL] [Abstract][Full Text] [Related]
40. Interval treatment of coronary artery disease with sustained-release isosorbide-5-mononitrate.
Jansen W; Prenze R; Kümper H; Tauchert M
Am J Cardiol; 1990 Jun; 65(21):16J-22J. PubMed ID: 2349913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
